The largest database of trusted experimental protocols

Tmpd n n n n tetramethyl p phenylenediamine dihydrochloride

Manufactured by Merck Group
Sourced in United States

TMPD (N,N,N′,N′-tetramethyl-p-phenylenediamine dihydrochloride) is a chemical compound used as a reagent in various laboratory applications. It is a colorless to pale yellow crystalline solid. TMPD is commonly used as an electron transfer agent and a redox indicator in biochemical and analytical procedures.

Automatically generated - may contain errors

4 protocols using tmpd n n n n tetramethyl p phenylenediamine dihydrochloride

1

Colorimetric Assay for COX-2 Inhibition

Check if the same lab product or an alternative is used in the 5 most similar protocols
COX-2 inhibition was measured by using a colorimetric COX-2 inhibitor screening assay kit (COX Activity Assay Kit, item No.760151) (Cayman Chemical, USA). The effect of PMG on COX-2 inhibition activity was performed according to the manufacturer's protocol. Cox-2 working solution was prepared by dissolving COX-2 agent in 100 mM Tris-HCl buffer, pH 8.0 at a ratio of 1 : 100. In brief, the reaction mixture containing 150 μl of assay buffer, 10 μl of PMG, 10 μl of heme (Cayman Chemical, USA), 10 μl of COX-II working solution, 20 μl of 10 μM TMPD (N,N,N′,N′-tetramethyl-p-phenylenediamine dihydrochloride) (Sigma, USA), and 20 μl of 100 μM arachidonic acid (Cayman Chemical, USA) was added to a 96-well microplates and incubated at 25°C for 30 minutes. At the end of the incubation time period, an absorbance at 590 nm was recorded and results were expressed as EC50 [22 (link)]. Indomethacin was used as a positive control.
+ Open protocol
+ Expand
2

Colorimetric COX-II Inhibition Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
To assess the cyclo-oxygenase-II (COX-II) inhibition, a colorimetric COX-II inhibitor screening assay kit (Cayman Chemical, USA) was employed. The extract’s anti-inflammatory effect on COX-II inhibition activity was determined following the manufacturer’s protocol. A COX-II working solution was prepared by dissolving the COX-II substance in 100 mM Tris-HCl buffer with a pH of 8.0, at a ratio of 1:100. In summary, a mixture containing 150 µL of assay buffer, 10 µL of the extract, 10 µL of heme (Cayman Chemical, USA), 10 µL of COX-II working solution, 20 µL of 10 µM TMPD (N, N,N’,N’-Tetramethyl-p-phenylenediamine dihydrochloride) (Sigma, USA), and 20 µL of 100 µM arachidonic acid (Cayman Chemical, USA) was added to 96-well microliter plates. The plates were then incubated at 25 °C for 30 min. Subsequently, the absorbance at 590 nm was measured, with indomethacin used as the reference standard [29 (link)]. The results were expressed as EC50 value.
+ Open protocol
+ Expand
3

Fatty Acid Metabolism Pathway Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sigma-Aldrich was chosen as the local supplier for the chemicals, drugs, and solvents used in this research. Arachidonic acid (CAT No: 152386) and linoleic acid (CAS No: 60-32-2) are fatty acids that are precursors to lipoxygenase (5-LOX) and cyclooxygenase (COX-2), respectively. Glutathione (GSH) (CAS 72-16-6), N, N,N,N-tetramethyl-p-phenylenediamine dihydrochloride (TMPD) (CAS 637-01-4), and hematin (CAS No. 15485-92-6) from Sigma-Aldrich serve as cofactors and indicators. Analytical grade solvents were used.
+ Open protocol
+ Expand
4

Mitochondrial Respiratory Function in Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
Synthetic THC (25 mg/mL in ethanol), mitochondrial complexes substrates and/or inhibitors such as glutamate, malate, amytal, ADP, succinate, ascorbate, antimycine, and N,N,N′,N′-tetramethyl-p-phenylenediaminedihydrochloride (tmpd) were acquired from Sigma-Aldrich, France. THC was successively diluted in ethanol as needed and Amplex Red and horseradish peroxidase (HRP) were acquired by Invitrogen. All other chemicals used were of the highest grade commercially available.
Ten male Wistar rats (weight 438 to 500 grams; age 13 weeks) were housed in a neutral temperature environment (22°  ± 2°C), on a 12 : 12 hours photoperiod, and were provided food and water ad libitum. This investigation was carried out in accordance with the Helsinki accords for human treatment of animals during experimentation. Rats were submitted to general anesthesia with 3% isoflurane and oxygen (2 L/min) in an induction chamber (Minerve, Esternay, France) and were then decapitated. Brains were excised and cleaned and then immediately used for the study of respiratory parameters.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!